Onyx Healthcare Inc. (TPEX:6569)
Taiwan · Delayed Price · Currency is TWD 92.20
+0.30 (0.33%)
Aug 19, 2026, 11:08 AM CST
Onyx Healthcare Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,452 | 1,313 | 1,241 | 1,493 | 1,600 | 1,202 | |
Revenue Growth | 8.88% | 5.80% | -16.85% | -6.71% | 33.16% | -10.80% |
Cost of Revenue | 975.2 | 879.27 | 784.98 | 936.72 | 1,128 | 838.03 |
Gross Profit | 477.22 | 434.02 | 456.28 | 556.14 | 472.31 | 363.73 |
Selling, General & Admin | 293.8 | 271.23 | 247.47 | 258.98 | 241.59 | 208.96 |
Research & Development | 110.93 | 112.49 | 118.32 | 79.36 | 86.67 | 79.35 |
Operating Expenses | 404.58 | 381.77 | 367.55 | 338.02 | 326.91 | 289.22 |
Operating Income | 72.64 | 52.24 | 88.73 | 218.12 | 145.39 | 74.51 |
Interest Expense | -6.03 | -4.68 | -4.36 | -3.68 | -3.56 | -2.63 |
Interest & Investment Income | 15.44 | 15.78 | 13.88 | 3.39 | 4.69 | 6.36 |
Earnings From Equity Investments | 77.48 | 68.51 | 67.1 | 62.87 | 62.94 | 50.19 |
Currency Exchange Gain (Loss) | -5.86 | -5.86 | 13.12 | -7.42 | 19.28 | -6.02 |
Other Non Operating Income (Expenses) | 59.13 | 3.59 | 18 | 19.85 | 25.41 | 18.57 |
EBT Excluding Unusual Items | 212.78 | 129.58 | 196.47 | 293.14 | 254.14 | 140.98 |
Gain (Loss) on Sale of Investments | -7.7 | -7.7 | 9.95 | 11.86 | -12.45 | -0.87 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.25 | - |
Other Unusual Items | 0.03 | 0.03 | -0.01 | 0.01 | 0.09 | -0.01 |
Pretax Income | 205.11 | 121.91 | 206.41 | 305 | 242.03 | 140.11 |
Income Tax Expense | 21.86 | 10.21 | 26.28 | 49.83 | 38.9 | 13.6 |
Earnings From Continuing Operations | 183.25 | 111.7 | 180.13 | 255.17 | 203.14 | 126.51 |
Minority Interest in Earnings | 0.39 | 0.43 | 0.79 | 0.09 | -0.18 | 1.04 |
Net Income | 183.65 | 112.13 | 180.91 | 255.26 | 202.96 | 127.55 |
Net Income to Common | 183.65 | 112.13 | 180.91 | 255.26 | 202.96 | 127.55 |
Net Income Growth | 49.12% | -38.02% | -29.13% | 25.77% | 59.12% | -23.66% |
Shares Outstanding (Basic) | 39 | 39 | 39 | 38 | 37 | 35 |
Shares Outstanding (Diluted) | 39 | 39 | 39 | 39 | 38 | 35 |
Shares Change | 0.62% | 0.45% | 0.61% | 2.85% | 7.68% | -0.14% |
EPS (Basic) | 4.71 | 2.88 | 4.69 | 6.66 | 5.43 | 3.67 |
EPS (Diluted) | 4.68 | 2.87 | 4.65 | 6.60 | 5.39 | 3.65 |
EPS Growth | 48.23% | -38.28% | -29.54% | 22.41% | 47.62% | -23.50% |
Free Cash Flow | -50.22 | 147.49 | 117.53 | 282.91 | 149.84 | -277.64 |
Free Cash Flow Per Share | -1.28 | 3.77 | 3.02 | 7.31 | 3.98 | -7.95 |
Dividend Per Share | - | 2.500 | 4.000 | 4.348 | 4.348 | 3.479 |
Dividend Growth | - | -37.50% | -8.01% | 0% | 25.00% | -20.00% |
Gross Margin | 32.86% | 33.05% | 36.76% | 37.25% | 29.51% | 30.27% |
Operating Margin | 5.00% | 3.98% | 7.15% | 14.61% | 9.09% | 6.20% |
Profit Margin | 12.64% | 8.54% | 14.57% | 17.10% | 12.68% | 10.61% |
Free Cash Flow Margin | -3.46% | 11.23% | 9.47% | 18.95% | 9.36% | -23.10% |
EBITDA | 88.62 | 67.57 | 105.12 | 235.93 | 163.63 | 90.84 |
EBITDA Margin | 6.10% | 5.15% | 8.47% | 15.80% | 10.22% | 7.56% |
D&A For EBITDA | 15.99 | 15.33 | 16.4 | 17.81 | 18.24 | 16.33 |
EBIT | 72.64 | 52.24 | 88.73 | 218.12 | 145.39 | 74.51 |
EBIT Margin | 5.00% | 3.98% | 7.15% | 14.61% | 9.09% | 6.20% |
Effective Tax Rate | 10.66% | 8.37% | 12.73% | 16.34% | 16.07% | 9.71% |